TScan Therapeutics Company
TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.
Connections from
Last Funding Type:
Series C
Funding Status:
IPO
Headquarters:
Waltham, Massachusetts, United States
Founded Date:
2018-01-01
Total Funding:
137500000
Employee Number:
51-100
Industry:
PharmTech